Quote | Super Quote
Code 
09820 GX CN BIOTECH-U
Fund Quote
RT
  • Underlying Asset:
  • Solactive China Biotech Index NTR
  • NAV: 
    (As at 12/11/2019)
  • 8.436
    Premium +0.17%
Fund Overview
Investment Target
To provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Solactive China Biotech Index NTR
Underlying Asset Solactive China Biotech Index NTR
Asset China
Base Currency RMB
Trading Currency USD
Board Lot Size 50
Dividend Policy Annual
Short Sell Allowed
ETF Type Physical
Derivatives Issuer N/A
Listing Date 25/07/2019
 
 
Fund Price Performance
Fund return performance is not including dividend.
Data updated on: 13/11/2019
 
 
Net Asset Value 8.436 USD (As at 12/11/2019)
Trust Unit outstanding
(Million)
16.650 (As at 12/11/2019)
Total Net Asset
(Million)
143.525 RMB (As at 14/10/2019)
 
Additional Data
Management Fee 0.5% p.a.
Stamp Duty Remission in full
Market Maker Flow Traders Hong Kong Limited
KGI Asia Limited
Mirae Asset Securities (HK) Limited
Fund Manager Mirae Asset Global Investments (Hong Kong) Limited
Website www.horizonsetfs.com.hk/en/horizons-etf/products/2820/overview.html
Document Download
Remark: Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Net asset value is subjected to the latest information released by issuers and daily updated.
Beware of delayed calculation of Premium/Discount(%).
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2019 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.